Precision, accuracy, cross reactivity and comparability of serum indices measurement on Abbott Architect c8000, Beckman Coulter AU5800 and Roche Cobas 6000 c501 clinical chemistry analyzers

Clinical Chemistry and Laboratory Medicine

Volumn 56, Issue 5, 2018, Pages 776-788

  Nikolac Gabaj, Nora ^a,b   Miler, Marijana ^a,b   Vrtarić, Alen ^a,b   Hemar, Marina ^a,d   Filipi, Petra ^a,e   Kocijančić, Marija ^a,f   Šupak Smolčić, Vesna ^a,g,h   Ćelap, Ivana ^a,b   Šimundić, Ana Maria ^a,c  

^a Croatian Society of Medical Biochemistry and Laboratory Medicine   (Croatia)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^c University Hospital Sveti Duh   (Croatia)

^d Policlinic Sunce   (Croatia)

^e UNIVERSITY HOSPITAL SPLIT   (Croatia)

^f Primary Health Care of Primorsko goranska County ^*  (Croatia)

^g KBC RIJEKA   (Croatia)

^h UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

analytical verification; hemolysis; icteria; interference; lipemia; preanalytical phase; serum indices

Indexed keywords

ARTICLE; ASSESSMENT OF HUMANS; BLOOD BIOCHEMISTRY; BLOOD SAMPLING; CLINICAL CHEMISTRY; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DILUTION; HEMOLYSIS; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MEASUREMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; REFERENCE VALUE; SERUM; THEORETICAL SAMPLE; BLOOD; BLOOD ANALYSIS; COMPARATIVE STUDY; HEALTH CARE QUALITY;

BILIRUBIN; LIPID;

BILIRUBIN; BLOOD CHEMICAL ANALYSIS; HEMOLYSIS; HUMANS; HYPERLIPIDEMIAS; LIPIDS; QUALITY OF HEALTH CARE;

EID: 85040904744     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2017-0889     Document Type: Article

References (31)

1. McCaughey EJ, Vecellio E, Lake R, Li L, Burnett L, Chesher D, et al. Current methods of haemolysis detection and reporting as a source of risk to patient safety: a narrative review. Clin Biochem Rev 2016;37:143-51.
2. Simundic AM, Nikolac N, Ivankovic V, Ferenec-Ruzic D, Magdic B, Kvaternik M, et al. Comparison of visual versus automated detection of lipemic, icteric and hemolyzed specimens: can we rely on a human eye? Clin Chem Lab Med 2009;47:1361-5.
3. Lippi G. Systematic assessment of the hemolysis index: pros and cons. Adv Clin Chem 2015;71:157-70.
4. Farrell CJ, Carter AC. Serum indices: managing assay interference. Ann Clin Biochem 2016;53(Pt 5):527-38.
5. Lippi G, Plebani M. Continuous-flow automation and hemolysis index: a crucial combination. J Lab Autom 2013;18:184-8.
6. Lippi G, Avanzini P, Campioli D, Da Rin G, Dipalo M, Aloe R, et al. Systematical assessment of serum indices does not impair efficiency of clinical chemistry testing: a multicenter study. Clin Biochem 2013;46:1281-4.
7. Clinical and Laboratory Standards Institute (CLSI). Hemolysis, icterus, and lipemia/turbidity indices as indicators of interference in clinical laboratory analysis; approved guideline. CLSI document C56-A. Wayne, PE, USA: Clinical and Laboratory Standards Institute, 2012.
8. Dolci A, Panteghini M. Harmonization of automated hemolysis index assessment and use: is it possible? Clin Chim Acta 2014;432:38-43.
9. Topic E, Nikolac N, Panteghini M, Theodorsson E, Salvagno GL, Miler M, et al. How to assess the quality of your analytical method? Clin Chem Lab Med 2015;53:1707-18.
10. Boyd JM, Krause R, Waite G, Hui W, Yazdi E, Wilmink D, et al. Developing optimized automated rule sets for reporting hemolysis, icterus and lipemia based on a priori outcomes analysis. Clin Chim Acta 2015;450:31-8.
11. Shin DH, Kim J, Uh Y, Lee SI, Seo DM, Kim KS, et al. Development of an integrated reporting system for verifying hemolysis, icterus, and lipemia in clinical chemistry results. Ann Lab Med 2014;34:307-12.
12. Clinical and Laboratory Standards Institute. Evaluation of Precision Performance of Quantitative measurement Methods; Approved Guideline, Second edition; EP5-A2. Wayne, PA, USA: Clinical and Laboratory Standards Institute, 2004.
13. McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb) 2012;22:276-82.
14. Nikolac N, Celap I, Filipi P, Hemar M, Kocijancic M, Miler M, et al. Croatian laboratories have a good knowledge of the proper detection and management of hemolyzed, icteric and lipemic samples. Clin Chem Lab Med 2016;54:419-25.
15. Dorotić A, Antončić D, Biljak VR, Nedić D, Beletić A. Hemolysis from a nurses' standpoint - survey from four Croatian hospitals. Biochem Med (Zagreb) 2015;25:393-400.
16. Lippi G, Luca Salvagno G, Blanckaert N, Giavarina D, Green S, Kitchen S, et al. Multicenter evaluation of the hemolysis index in automated clinical chemistry systems. Clin Chem Lab Med 2009;47:934-9.
17. Lippi G. Interference studies: focus on blood cell lysates preparation and testing. Clin Lab 2012;58:351-5.
18. Clinical and Laboratory Standards Institute (CLSI). Reference and Selected Procedures for the Quantitative Determination of Hemoglobin in Blood; Approved Standard, Third Edition. CLSI document H15A3. Wayne, PE, USA: Clinical and Laboratory Standards Institute, 2000.
19. Han V, Serrano K, Devine DV. A comparative study of common techniques used to measure haemolysis in stored red cell concentrates. Vox Sang 2010;98:116-23.
20. Fernandez P, Llopis MA, Perich C, Alsina MJ, Alvarez V, Biosca C, et al. Harmonization in hemolysis detection and prevention. A working group of the Catalonian Health Institute (ICS) experience. Clin Chem Lab Med 2014;52:1557-68.
21. Kroll MH, McCudden CR. Endogenous interferences in clinical laboratory tests. Icteric, lipemic and turbid samples. Berlin/Boston: Walter de Gruyter GmbH, 2013.
22. Alvarez F, Whalen K, Scott MG. Conjugated, but not unconjugated, bilirubin negatively interferes in Hitachi 747 assay of inorganic phosphorus. Clin Chem USA 1993;39:2345-6.
23. Nikolac Gabaj N, Miler M, Mihic R. I index is not an accurate indicator of icteria in conjugated hyperbilirubinemia. Clin Chim Acta 2017;473:32-4.
24. Salinas M, López-Garrigós M, Lugo J, Gutiérrez M, Flors L, Leiva-Salinas C. Diagnostic accuracy of icteric index to detect abnormal total bilirubin values. J Clin Pathol 2012;65: 928-33.
25. Nicolay A, Lorec AM, Gomez G, Portugal H. Icteric human samples: icterus index and method of estimating an interferencefree value for 16 biochemical analyses. J Clin Lab Anal 2017. doi: 10.1002/jcla.22229. [Epub ahead of print].
26. Nikolac N, Simundic AM, Miksa M, Lima-Oliveira G, Salvagno GL, Caruso B, et al. Heterogeneity of manufacturers' declarations for lipemia interference - urgent call for standardization. Clin Chim Acta 2013;426:33-40.
27. Grunbaum AM, Gilfix BM, Hoffman RS, Lavergne V, Morris M, Miller-Nesbitt A, et al. Review of the effect of intravenous lipid emulsion on laboratory analyses. Clin Toxicol (Phila) 2016;54:92-102.
28. Nikolac N. Lipemia: causes, interference mechanisms, detection and management. Biochem Med (Zagreb) 2014;24:57-67.
29. Twomey PJ, Don-Wauchope AC, McCullough D. Unreliability of triglyceride measurement to predict turbidity induced interference. J Clin Pathol 2003;56:861-2.
30. Lippi G, Giavarina D, Gelati M, Salvagno GL. Reference range of hemolysis index in serum and lithium-heparin plasma measured with two analytical platforms in a population of unselected outpatients. Clin Chim Acta 2014;429:143-6.
31. Petrova DT, Cocisiu GA, Eberle C, Rhode KH, Brandhorst G, Walson PD, et al. Can the Roche hemolysis index be used for automated determination of cell-free hemoglobin? A comparison to photometric assays. Clin Biochem 2013;46:1298-301.